Asia / TAIWAN
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
PET Pharm Biotech Co., Ltd. manufactures molecular imaging medicines. Its products include Naolixi Injection, FDG Fluodeoxy glucose Injection, Sodium fluoride injection and Radioactive sodium iodide capsules. The company was founded on October 01, 2011 and is headquartered in New Taipei city, Taiwan.
PET Pharm Biotech Co., Ltd. manufactures molecular imaging medicines. Its products include Naolixi Injection, FDG Fluodeoxy glucose Injection, Sodium fluoride injection and Radioactive sodium iodide capsules. The company was founded on October 01, 2011 and is headquartered in New Taipei city, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | TAIWAN |
| Employees | 60 |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Wright ID | C158H3X4K |
Key Metrics
| Current price | $54.80 |
| Market cap | $3.18 B |
| P/E ratio | 106.02 |
| 52-week perf. | -27.4% |
| Common shares | 58.1 M |
| Share type | Gu |
| Quality rating | LAD0 |
| Dividend yield | 0.44% |
Recent stock performance
| 1 Week | +4.2% |
| 4 Week | +0.6% |
| 13 Week | +17.5% |
Officers
n/a
Address
TAIWAN
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.